Biological correlates of FDG uptake in non-small cell lung cancer LF de Geus-Oei, JHJM van Krieken, RP Aliredjo, PFM Krabbe, C Frielink, ... Lung cancer 55 (1), 79-87, 2007 | 251 | 2007 |
A prospective multi-centre study of the value of FDG-PET as part of a structured diagnostic protocol in patients with fever of unknown origin CP Bleeker-Rovers, FJ Vos, AH Mudde, ASM Dofferhoff, LF de Geus-Oei, ... European journal of nuclear medicine and molecular imaging 34, 694-703, 2007 | 248 | 2007 |
Monitoring and predicting response to therapy with 18F-FDG PET in colorectal cancer: a systematic review LF de Geus-Oei, D Vriens, HWM van Laarhoven, WTA van der Graaf, ... Journal of Nuclear Medicine 50 (Suppl 1), 43S-54S, 2009 | 247 | 2009 |
Predictive and prognostic value of FDG‐PET in nonsmall‐cell lung cancer: a systematic review LF de Geus‐Oei, HFM van der Heijden, FHM Corstens, WJG Oyen Cancer 110 (8), 1654-1664, 2007 | 184 | 2007 |
The role of 18fluoro‐2‐deoxyglucose positron emission tomography in initial staging and re‐staging after chemotherapy for testicular germ cell tumours JR Spermon, LF De Geus‐Oei, L Kiemeney, JA Witjes, WJG Oyen BJU international 89 (6), 549-556, 2002 | 178 | 2002 |
Chemotherapy response evaluation with 18F-FDG PET in patients with non-small cell lung cancer LF de Geus-Oei, HFM van der Heijden, EP Visser, R Hermsen, ... Journal of nuclear medicine 48 (10), 1592-1598, 2007 | 175 | 2007 |
PET/MRI in head and neck cancer: initial experience I Platzek, B Beuthien-Baumann, M Schneider, V Gudziol, J Langner, ... European journal of nuclear medicine and molecular imaging 40, 6-11, 2013 | 167* | 2013 |
18F-FDG PET reduces unnecessary hemithyroidectomies for thyroid nodules with inconclusive cytologic results LF de Geus-Oei, GFFM Pieters, JJ Bonenkamp, AH Mudde, ... Journal of Nuclear Medicine 47 (5), 770-775, 2006 | 157 | 2006 |
Comparison of image-derived and arterial input functions for estimating the rate of glucose metabolism in therapy-monitoring 18F-FDG PET studies LF de Geus-Oei, EP Visser, PFM Krabbe, BA van Hoorn, EB Koenders, ... Journal of Nuclear Medicine 47 (6), 945-949, 2006 | 154 | 2006 |
18F-FDG PET early response evaluation of locally advanced non–small cell lung cancer treated with concomitant chemoradiotherapy EA Usmanij, LF de Geus-Oei, EGC Troost, L Peters-Bax, ... Journal of Nuclear Medicine 54 (9), 1528-1534, 2013 | 148 | 2013 |
Scintigraphic techniques for early detection of cancer treatment–induced cardiotoxicity LF de Geus-Oei, AMC Mavinkurve-Groothuis, L Bellersen, M Gotthardt, ... Journal of nuclear medicine technology 41 (3), 170-181, 2013 | 141 | 2013 |
Glucose metabolism in NSCLC is histology-specific and diverges the prognostic potential of 18FDG-PET for adenocarcinoma and squamous cell carcinoma OCJ Schuurbiers, TWH Meijer, JHAM Kaanders, MG Looijen-Salamon, ... Journal of Thoracic Oncology 9 (10), 1485-1493, 2014 | 136 | 2014 |
Chemotherapy response evaluation with FDG–PET in patients with colorectal cancer LF de Geus-Oei, HWM van Laarhoven, EP Visser, R Hermsen, ... Annals of Oncology 19 (2), 348-352, 2008 | 134 | 2008 |
Differences in metabolism between adeno-and squamous cell non-small cell lung carcinomas: spatial distribution and prognostic value of GLUT1 and MCT4 TWH Meijer, OCJ Schuurbiers, JHAM Kaanders, MG Looijen-Salamon, ... Lung cancer 76 (3), 316-323, 2012 | 132 | 2012 |
Methodological considerations in quantification of oncological FDG PET studies D Vriens, EP Visser, LF de Geus-Oei, WJG Oyen European journal of nuclear medicine and molecular imaging 37, 1408-1425, 2010 | 132 | 2010 |
A comparison of the diagnostic value of MRI and 18F-FDG-PET/CT in suspected spondylodiscitis C Smids, IJE Kouijzer, FJ Vos, T Sprong, AJF Hosman, JWJ de Rooy, ... Infection 45, 41-49, 2017 | 122 | 2017 |
The role of [18F]‐2‐fluoro‐2‐deoxy‐d‐glucose–positron emission tomography in thyroid nodules with indeterminate fine‐needle aspiration biopsy: Systematic … D Vriens, JHW de Wilt, GJ van der Wilt, RT Netea‐Maier, WJG Oyen, ... Cancer 117 (20), 4582-4594, 2011 | 119 | 2011 |
PET in the management of locally advanced and metastatic NSCLC W Grootjans, LF de Geus-Oei, EGC Troost, EP Visser, WJG Oyen, ... Nature reviews Clinical oncology 12 (7), 395-407, 2015 | 108 | 2015 |
A curve-fitting approach to estimate the arterial plasma input function for the assessment of glucose metabolic rate and response to treatment D Vriens, LF de Geus-Oei, WJG Oyen, EP Visser Journal of Nuclear Medicine 50 (12), 1933-1939, 2009 | 98 | 2009 |
The impact of optimal respiratory gating and image noise on evaluation of intratumor heterogeneity on 18F-FDG PET imaging of lung cancer W Grootjans, F Tixier, CS van der Vos, D Vriens, CC Le Rest, J Bussink, ... Journal of nuclear medicine 57 (11), 1692-1698, 2016 | 91 | 2016 |